Company news

Amphastar Pharmaceuticals, Inc. news in 2023

Amphastar Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Amphastar Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

November 19, 2023

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023

November 7, 2023

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023

October 31, 2023

Amphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior Notes

September 12, 2023

Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes

September 10, 2023

Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference

August 30, 2023

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023

August 7, 2023

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023

August 1, 2023

Amphastar Pharmaceuticals Completes Acquisition of BAQSIMI from Lilly

June 29, 2023

Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference

May 30, 2023

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2023

May 8, 2023

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2023

May 2, 2023

Lilly to Divest BAQSIMI to Amphastar

April 23, 2023

Amphastar Pharmaceuticals Business Update and Hold Conference Call on April 24th, 2023

April 23, 2023

Amphastar Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference

April 11, 2023

Amphastar Pharmaceuticals Receives FDA Approval for Naloxone Hydrochloride Nasal Spray 4mg

March 7, 2023

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2022

February 27, 2023

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2023

February 21, 2023

Calls in 2023

Decks in 2023